Conference Coverage: EHA 2023 – Focus on Myelofibrosis (MF)

MF specific discussions on therapeutic advances and their application in clinical decision-making

June 14, 2023

Faculty Chair

John Mascarenhas, MD

Mount Sinai, New York, NY, USA

Faculty Members

Abdulraheem Yacoub, MD
University of Kansas, Lawrence, KS, USA

Kristen Pettit, MD
University of Michigan, Ann Arbor, MI, USA

Ellen K. Ritchie, MD
Weill Cornell Medicine, New York, NY, USA

Gabriela Hobbs, MD
Massachusetts General Hospital, Boston, MA, USA

Sample Report

Start discovering the insights

View Report


  • Risk-Adapted Therapy in MF
  • JAK Inhibitor-Refractory MF
  • Advances in JAK Inhibitors Monotherapy and Combinations
  • Beyond JAK Inhibitors

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.